Abdullah A. Tarique

Brisbane, QLD 4101, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosis.

Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 27, 2026

Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial.

Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial.

Journal: BMJ open

Published: September 21, 2025

CFTR is required for zinc-mediated antibacterial defense in human macrophages.

CFTR is required for zinc-mediated antibacterial defense in human macrophages.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 16, 2024

Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis.

Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis.

Journal: Cells

Published: December 22, 2023

Cytotoxic and Bactericidal Effects of Inhalable Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticles with Traces of Zinc Oxide.

Cytotoxic and Bactericidal Effects of Inhalable Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticles with Traces of Zinc Oxide.

Journal: International journal of molecular sciences

Published: January 31, 2023

Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis.

Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: December 16, 2019

TLR Crosstalk Activates LRP1 to Recruit Rab8a and PI3Kγ for Suppression of Inflammatory Responses.

TLR Crosstalk Activates LRP1 to Recruit Rab8a and PI3Kγ for Suppression of Inflammatory Responses.

Journal: Cell reports

Published: January 04, 2018

Differential expression of genes and receptors in monocytes from patients with cystic fibrosis.

Differential expression of genes and receptors in monocytes from patients with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: December 12, 2017

CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis.

CFTR-dependent defect in alternatively-activated macrophages in cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: December 15, 2016

Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages.

Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages.

Journal: American journal of respiratory cell and molecular biology

Published: April 15, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026